Recent Updates
Recently added Catalysts
SNY

Sanofi: Information concerning the total number of voting rights and shares - September 2022

Key Takeaway: Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlement général de l’Autorité des Marchés Financiers (Regulation of the French stock mark
Price reaction · baseline $39.24 (2022-10-12 close) · hit after-hours · clean, no other SNY news in the window
day 0 close · peak
+1.7%

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+11%
120-day peak, hindsight
Typical move
1.8%
average across 15 past catalysts
Lead asset
teplizumab/mL
Phase 2 · Diabetes Mellitus, Type 1

Full Press Release Details

Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlement général de l’Autorité des Marchés Financiers (Regulation of the French stock market authority)
a French société anonyme with a registered share capital of 2,534,952,234 €
Registered office : 54, rue La Boétie - 75008 Paris - France
Registered at the Paris Commercial and Companies Registry under number 395 030 844
Date Total number of issued shares Number of real voting rights (excluding treasury shares) Theoretical number of voting rights (including treasury shares)*
September 30, 2022 1,267,479,766 1,411,899,228 1,425,326,874
* Pursuant to article 223-11 of the Règlement général de l’Autorité des Marchés Financiers.
This information is also available on the internet website of sanofi under « Regulated Information in France »:
EN_number_of_voting_rights_and_shares_SEPTEMBER_2022
Last updated: Oct 13, 2022